← Back to Search

Procedure

Patients having vaginal delivery for Vaginal Bleeding (ELUSIVE Trial)

N/A
Waitlist Available
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pregnant women between the ages of 18-50. Plan of care is vaginal delivery.
Incarcerated patients. Patient unwilling or unable to provide consent. Intrauterine fetal demise (no fetal heart beat identified and documented by two physicians).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of vaginal delivery
Awards & highlights

ELUSIVE Trial Summary

This trial will test a new device that is used to assess blood loss in mothers during and after childbirth. The device will be used on mothers who consent to participate in the study, and data will be collected from these mothers to compare the accuracy of the device to standard methods of assessment.

Eligible Conditions
  • Blood Loss
  • Vaginal Bleeding
  • Postpartum Hemorrhage
  • Vaginal Birth

ELUSIVE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

ELUSIVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of vaginal delivery
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of vaginal delivery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Differences in Blood Loss Between Cases and Controls Using Clinical Estimate (Visual EBL) Versus Device Assessment (QBL).

ELUSIVE Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients having vaginal deliveryExperimental Treatment1 Intervention
EBL will be estimated visually vs quantitatively at time of vaginal delivery.

Find a Location

Who is running the clinical trial?

The University of Texas Medical Branch, GalvestonLead Sponsor
240 Previous Clinical Trials
56,339 Total Patients Enrolled
Antonio Saad, MDStudy DirectorUTMB
7 Previous Clinical Trials
2,151 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Mar 2025